Previous Section Index Home Page

3 Apr 2008 : Column 1290W—continued


Departmental Expenditure

Mr. Gerald Howarth: To ask the Secretary of State for Health if he will break down, by sub-head in (a) near cash and (b) non-cash terms his Department's (i) gross resource outturn, (ii) operating appropriations in aid outturn, (iii) gross capital outturn and (iv) non-operating appropriations in aid outturn for financial years 2001-02 to 2006-07. [191678]

Mr. Bradshaw: The figures for final and provisional outturns are published each year in Public Expenditure Outturn White Papers (PEOWP), which are available in the Library. The paper references are:

PEOWP Reference

2001-02

CM5574

2002-03

CM5884

2003-04

CM6293

2004-05

CM6639

2005-06

CM6883

2006-07

CM7156


The differences between provisional and final outturns are published in Public Expenditure Statistical Analyses (PESA) papers, which are available in the Library. The paper references are:

PESA Reference

2002

CM4602 to CM4621

2003

CM5901

2004

CM6201

2005

CM6521

2006

CM6811

2007

CM7091


Departmental Sustainable Development

Norman Baker: To ask the Secretary of State for Health when his Department plans to publish its sustainable operations policy statement. [195870]

Mr. Ivan Lewis: The Department publishes its sustainable operations commitments as part of its Sustainable Development Action Plan. We also report annually to the Sustainable Development Commission on our progress against the Sustainable Operations on the Government Estate (SOGE) targets. The results of the latest SOGE exercise have recently been published, and we were in first place overall.

Disease Control

Mr. Oaten: To ask the Secretary of State for Health what guidance he has issued on the appointment of authorised persons to inspect (a) central sterile stores and (b) management of infection control. [197642]

Ann Keen: The Department has issued guidance on the management and environment for the decontamination of reusable medical devices in “Health Technical Memorandum (HTM) 01-01): Decontamination of reusable medical devices”. Part A of HTM 01-01 identifies the
3 Apr 2008 : Column 1291W
functional responsibilities including ‘Authorised Persons (Decontamination)’ to ensure equipment is operated safely and efficiently. A copy of HTM 01-01 Part A has been placed in the Library.

The role of the Director of Infection Prevention and Control (DIPC) was first set out in “Winning Ways—working together to reduce healthcare associated infection in England” a report by the Chief Medical Officer which was published in December 2003. A copy of this publication is available in the Library. Guidance on competences for DIPCs was issued in May 2004.

Drugs: Babies

Norman Lamb: To ask the Secretary of State for Health how many children were born with drug-dependency problems in each of the last five years, broken down by (a) region and (b) type of drug. [195451]

Dawn Primarolo: The following tables show the number of finished consultant episodes (FCEs) where the primary or secondary diagnosis was either neonatal withdrawal symptoms from maternal use of drugs addiction or withdrawal symptoms from therapeutic use of drugs in newborn. Information is provided for the years 2002-03 to 2006-07, which is the latest data available, broken down by strategic health authority (SHA) of residence. It is not possible to provide information for what type of drug a newborn baby is addicted to.

Count of cases (FCEs) with a primary or secondary diagnosis of neonatal withdrawal symptoms from maternal use of drugs by SHA of residence for the period 2006-07
SHA of Residence Total finished consultant birth episodes

North East SHA

52

North West SHA

100

Yorkshire and The Humber SHA

163

East Midlands SHA

64

West Midlands SHA

82

East of England SHA

95

London SHA

66

South East Coast SHA

40

South Central SHA

20

South West SHA

60

Other and unknown

469

Total

1,211



3 Apr 2008 : Column 1292W

3 Apr 2008 : Column 1293W
Count of cases (finished consultant birth episodes) with a primary or secondary diagnosis of neonatal withdrawal symptoms from maternal use of drugs by SHA of residence for the period 2002-03 to 2005-06
Total finished consultant birth episodes
SHA of Residence 2005-06 2004-05 2003-04 2002-03

Norfolk, Suffolk and Cambridgeshire SHA

*

*

*

*

Bedfordshire and Hertfordshire SHA

12

16

10

0

Essex SHA

0

8

*

*

North West London SHA

11

11

11

8

North Central London SHA

12

13

*

*

North East London SHA

*

0

*

0

South East London SHA

*

*

*

8

South West London SHA

*

0

*

0

Northumberland, Tyne and Wear SHA

6

*

*

*

County Durham and Tees Valley SHA

17

30

40

28

North & East Yorkshire and Northern Lincolnshire SHA

23

27

45

45

West Yorkshire SHA

13

11

27

17

Cumbria and Lancashire SHA

7

13

16

33

Greater Manchester SHA

10

8

11

39

Cheshire and Merseyside SHA

54

63

40

38

Thames Valley SHA

7

*

*

*

Hampshire and Isle of Wight SHA

*

9

7

*

Kent and Medway SHA

0

*

*

*

Surrey and Sussex SHA

13

11

13

18

Avon, Gloucestershire and Wiltshire SHA

62

40

44

51

South West Peninsula SHA

17

17

10

16

Dorset and Somerset SHA

28

8

9

12

South Yorkshire SHA

*

*

*

*

Trent SHA

6

8

10

8

Leicestershire, Northamptonshire and Rutland SHA

21

*

0

0

Shropshire and Staffordshire SHA

13

6

12

*

Birmingham and the Black Country SHA

*

*

*

*

West Midlands South SHA

*

0

6

11

Other and Unknown

860

873

817

694

Total

1,211

1,193

1,156

1,054

Notes:
1. Coverage and data quality:
The maternity tail data coverage is not as complete as the rest of HES data. There are a number of reasons for the coverage and data quality issues such as:
trusts submitting a significantly higher number of delivery episodes compared to birth episodes;
trusts failing to submit data on the number of birth episodes where they record a high number of delivery episodes;
trusts failing to submit delivery - the reason for this is that approximately 20 trusts have a stand alone maternity system which is not linked to the Patient Administration System;
trusts identifying a high number of maternity beds available, but not recording any information about deliveries or births;
trusts identifying that they have no maternity beds available, but recording a high number of birth and delivery episodes; and
Some trusts have space in their maternity system to record nine birth tails, whereas other systems have space for 18. As deliveries, miscarriages and abortions are all recorded in the birth tail, there are cases where nine tails is not enough to record all of the relevant data.
2. Between 2001-02 and 2005-06, coverage of hospital deliveries was 72.6 per cent., on average, whereas that of home deliveries was 13.6 per cent., on average. The incomplete coverage problem is significantly compounded by the data quality issues outlined.
3. Assessing growth through time:
HES figures are available from 1989-90 onwards. During the years that these records have been collected the NHS there have been ongoing improvements in quality and coverage. These improvements in information submitted by the NHS have been particularly marked in the earlier years and need to be borne in mind when analysing time series.
Some of the increase in figures for later years (particularly 2006-07 onwards) may be due to the improvement in the coverage of independent sector activity.
Changes in NHS practice also need to be borne in mind when analysing time series. For example a number of procedures may now be undertaken in outpatient settings and may no longer be accounted in the HES data. This may account for any reductions in activity over time.
4. FCE:
A FCE is defined as a period of admitted patient care under one consultant within one health care provider. The figures do not represent the number of patients, as a person may have more than one episode of care within the year.
5. All Diagnoses count of episodes:
These figures represent a count of all FCE’s where the diagnosis was mentioned in any of the 14 (seven prior to 2002-03) diagnosis fields in a HES record.
International Classification of Diseases (ICD)-IO diagnosis codes used:
P96.1 Neonatal withdrawal symptoms form maternal use of drugs of addiction.
P96.2 Withdrawal symptoms form therapeutic use of drugs in newborn.
6. Low Numbers:
Due to reasons of confidentiality, figures between one and five have been suppressed and replaced with ‘*’ (an asterisk).
7. Ungrossed Data:
Figures have not been adjusted for shortfalls in data (i.e. the data are ungrossed).
Source:
Hospital Episode Statistics (HES), The Information Centre for health and social care.

Next Section Index Home Page